Ovarian hormones and propensity to drug relapse: A review

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 3, 2011, Pages 427-436

  Hudson, Amanda ^a   Stamp, Jennifer A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Addiction; Estradiol; Ovarian hormones; Progesterone; Reinstatement; Relapse; Sex differences

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALCOHOL; AMPHETAMINE; COCAINE; DOPAMINE; DRUGS USED IN THE TREATMENT OF ADDICTION; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR AGONIST; HORMONE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROGESTERONE; SEX HORMONE; UNCLASSIFIED DRUG;

ALCOHOLISM; ANXIETY; ASSOCIATION; BRAIN DAMAGE; CIGARETTE SMOKING; COCAINE DEPENDENCE; DEPRESSION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; ESTRUS CYCLE; FOLLICULAR PHASE; HORMONAL THERAPY; HORMONE ACTION; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; MENTAL STRESS; MOOD DISORDER; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; OVARY; OVARY CYCLE; PRIORITY JOURNAL; RELAPSE; REVIEW; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME;

ANIMALS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GONADAL HORMONES; HUMANS; MALE; MENSTRUAL CYCLE; SEX CHARACTERISTICS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 78649903460     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.05.001     Document Type: Review

References (109)

1. Andreano J.M., Hamidreza A., Cahill L. Menstrual cycle modulation of the relationship between cortisol and long-term memory. Psychoneuroendocrinology 2008, 33:874-882.
2. Anker J.J., Larson E.B., Gliddon L.A., Carroll M.E. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Exp. Clin. Psychopharm. 2007, 15:472-480.
3. Anker J.J., Holtz N.A., Zlebnik N., Carroll M.E. Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats. Psychopharmacology 2009, 203:63-72.
4. Anker J.J., Carroll M.E. Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug Alcohol Depend 2010, 107:264-267.
5. Avants S.K., Margolin A., Kosten T.R., Cooney N.L. Differences between responders and nonresponders to cocaine cues in the laboratory. Addict. Behav. 1995, 20:215-224.
6. Basso A.M., Spina M., Rivier J., Vale W., Koob G.F. Corticotropin releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology 1999, 145:21-31.
7. Becker J.B. Direct effect of 17B-estradiol on striatum: sex differences in dopamine release. Synapse 1990, 5:157-164.
8. Becker J.B. Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci. Lett. 1990, 118:169-171.
9. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 1999, 64:803-812.
10. Becker J.B., Cha J.H. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav. Brain Res. 1989, 35:117-125.
11. Becker J.B., Hu M. Sex differences in drug abuse. Front. Neuroendocrinol. 2008, 29:36-47.
12. Brady K.T., Randall C.L. Gender differences in substance use disorders. Psychiat. Clin. N. Am. 1999, 22:241-452.
13. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., Goodman J.M., Kantor H.L., Gastfriend D.R., Riorden J.P., Mathew R.T., Rosen B.R., Hyman S.E. Acute effects of cocaine on human brain activity and emotion. Neuron 1997, 19:591-611.
14. Capriles N., Rodaros D., Sorge R.E., Stewart J. A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology 2003, 168:66-74.
15. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 2004, 25:273-279.
16. Collins A., Eneroth P., Landgren B.M. Psychoneuroendocrine stress responses and mood as related to the menstrual cycle. Psychosom. Med. 1985, 47:512-527.
17. Cornish J., Kalivas P. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J. Neurosci. 2000, 20:1-5.
18. Cyr M., Ghribi O., Thibault C., Morissette M., Landry M., Di Paolo T. Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res. Rev. 2001, 37:153-161.
19. Da Silva J.A.P. Sex hormones and glucocorticoids: interactions with the immune system. Ann. N. Y. Acad. Sci. 2006, 876:102-118.
20. Deroche V., Marinelli M., Le Moal M., Piazza P.V. Glucocorticoids and behavioral effects of psychostimulants II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J. Pharmacol. Exp. Ther. 1997, 281:1401-1407.
21. De Vries T., Schoffelmeer A., Binnekade R., Vanderschuren L. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology 1999, 143:254-260.
22. Di Ciano P., Cardinal R.N., Cowell R.A., Little S.J., Everitt B.J. Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of Pavlovian approach behavior. J. Neurosci. 2001, 21:9471-9477.
23. Di Ciano P., Everitt B.J. Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 2001, 25:341-360.
24. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev. Neurosci. 1994, 5:27-41.
25. Dluzen D.E., Ramirez V.D. Intermittent infusion of progesterone potentiates whereas continuous infusion reduces amphetamine-stimulated dopamine release from ovariectomized estrogen-primed rat striatal fragments superfused in vitro. Brain Res. 1987, 406:1-9.
26. Dluzen D.E., Ramirez V.D. Bimodal effect of progesterone on in vitro dopamine function of the rat corpus striatum. Neuroendocrinology 1984, 39:149-155.
27. Dreher J.C., Schmidt P.J., Kohn P., Furman D., Rubinow D., Berman K.F. Menstrual cycle phase modulates reward-related neural function in women. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2465-2470.
28. Elman I., Karlsgodt K.H., Gastfriend D.R. Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence. Am. J. Drug Alcohol Abuse 2001, 27:193-203.
29. Epstein D.H., Preston K.L., Stewart J., Shaham Y. Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology 2006, 189:1-16.
30. Evans S.M. The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp. Clin. Psychopharm. 2007, 15:418-426.
31. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31:659-674.
32. Facchinetti F., Martignoni E., Fioroni L., Sances G., Genazzani A.R. Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. Cephalagia 1990, 10:51-56.
33. Feltenstein M.W., See R.E. Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav. Brain Res. 2007, 174:1-8.
34. Feltenstein M.W., Byrd E.A., Henderson A.R., See R.E. Attenuation of cocaine seeking by progesterone treatment in female rats. Psychoneuroendocrinology 2009, 34:343-352.
35. Franklin T.R., Napier K., Ehrman R., Gariti P., O'Brien C.P., Childress A.R. Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob. Res. 2004, 6:171-175.
36. Fuchs R.A., Evans K.A., Mehta R.H., Case J.M., See R.E. Influence of sex and estrous cyclicity on conditioned cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology 2005, 179:662-672.
37. Gallop R.J., Crits-Christoph P., Ten Have T.R., Jacques P., Barber J.P., Frank A., Griffin M.L. Differential transitions between cocaine use and abstinence for men and women. J. Consult. Clin. Psychol. 2007, 75:95-103.
38. Gritz E.R. Smoking behavior and tobacco abuse. Advances in Substance Abuse 1980, 91-158. JA1 Press, Greenwich. N.K. Mello (Ed.).
39. Hall N.R., Goldstein A.L. Endocrine regulation of host immunity. Immune Modulation Agents and Their Mechanisms 1984, 533-563. Dekker, New York. R.L. Fenichel, M.A. Chirigos (Eds.).
40. Hammer R.P. μ-Opiate receptor binding in the medial preoptic area is cyclical and sexually dimorphic. Brain Res. 1990, 515:187-192.
41. Heinrichs S.C., Menzaghi F., Schulteis G., Koob G.F., Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav. Pharmacol. 1995, 6:74-80.
42. Holdstock L., de Wit H. Effects of ethanol at four phases of the menstrual cycle. Psychopharmacology (Berl.) 2000, 150:374-382.
43. Hunt W.A., Barnett L.W., Branch L.G. Relapse rates in addiction programs. J. Clin. Psychol. 1971, 27:455-456.
44. Hunt W.A., Matarazzo J.E. Three years later: recent developments in the experimental modification of smoking behavior. J. Abnorm. Psychol. 1973, 81:107-114.
45. Irwin R.P., Lin S.Z., Rogawski M.A., Purdy R.H., Paul S.M. Steroid potentiation and inhibition of N-methyl-d-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies. ASPET 1994, 271:677-682.
46. Jezova D., Skultetyova I., Tokarev D.I., Bakos P., Vigas M. Vasopressin and oxytocin in stress. Ann. N. Y. Acad. Sci. 1995, 771:192-203.
47. Justice A.J., de Wit H. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 2000, 71:51-59.
48. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 2005, 162:1403-1413.
49. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci. Biobehav. Rev. 2004, 27:765-776.
50. Kippin T.E., Fuchs R.A., Mehta R.H., Case J.M., Parker M.P., Bimonte-Nelson H.A., See R.E. Potentiation of cocaine-primed reinstatement of drug seeking in female rats during estrus. Psychopharmacology 2005, 182:245-252.
51. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 1999, 61:154-162.
52. Klein L.C., Popke J.E., Grunberg N.E. Sex differences in effects of predictable and unpredictable footshock on fentanyl selfadministration in rats. Exp. Clin. Psycopharmacol. 1997, 5:99-106.
53. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., O'Dell L.E., Parsons L.H., Sanna P.P. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 2004, 27:739-749.
54. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278:52-58.
55. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
56. Kosten T.A., Gawin F.H., Kosten T.R., Rounsaville B.J. Gender differences in cocaine use and treatment response. J. Subst. Abuse Treat. 1993, 10:63-66.
57. Kreek M.J. Multiple drug abuse patterns and medical consequences. Psychopharmacology: The Third Generation of Progress 1987, 1597-1604. Raven Press, New York. H.Y. Meltzer (Ed.).
58. Larson E.B., Anker J.J., Gliddon L.A., Fons K.S., Carroll M.E. Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access. Exp. Clin. Psychopharm. 2007, 15:461-471.
59. Larson E.B., Carroll M.E. Estrogen receptor β, but not α, mediates estrogen's effect on cocaine-induced reinstatement of extinguished cocaine-seeking behavior in ovariectomized female rats. Neuropsychopharmacology 2006, 32:1334-1345.
60. Larson E.B., Roth M.E., Anker J.J., Carroll M.E. Effect of short- vs. long-term estrogen on reinstatement of cocaine-seeking behavior in female rats. Pharmacol. Biochem. Behav. 2005, 82:98-108.
61. Lynch W.J., Carroll M.E. Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology 2000, 148:196-200.
62. Markou A., Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 1991, 1:17-26.
63. Markou A., Weiss F., Gold L.H., Caine S.B., Schulteis G., Koob G.F. Animal models of drug craving. Psychopharmacology 1993, 112:163-182.
64. Marlatt G.A., Gordon J.R. Determinants of relapse: implications for the maintenance of behavior change. Behavioral Medicine: Changing Health Lifestyles 1980, 410-452. Pergamon, Elmsford, NY. P.O. Davidson, S.M. Davidson (Eds.).
65. Relapse Prevention: Maintenance Strategies in Addictive Behavior Change 1985, Guilford, New York. G.A. Marlatt, J.R. Gordon (Eds.).
66. Mastorakos G., Zapanti E. The hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone. Nutr. Neurosci. 2004, 7:271-280.
67. McCarthy M.M., Becker J.B. Neuroendocrinology of sexual behavior in the female. Behavioral Endocrinology 2002, 117-151. MIT Press/Bradford Books, Cambridge. J.B. Becker, S.M. Breedlove, D. Crews, M.M. McCarthy (Eds.).
68. McKay J.R., Rutherford M.J., Cacciola J.S., Kabasakalian-McKay R., Alterman A.I. Gender differences in the relapse experiences of cocaine patients. J. Nerv. Ment. Dis. 1996, 184:616-622.
69. McFarland K., Davidge S.B., Lapish C.C., Kalivas P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 2004, 24:1551-1560.
70. McFarland K., Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2001, 21:8655-8663.
71. McFarland K., Lapish C.C., Kalivas P.W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2003, 23:3531-3537.
72. Naqvi N.H., Rudrauf D., Damasio H., Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science 2007, 315:531-534.
73. Negrete J.C., Emil S. Cue-evoked arousal in cocaine users: a study of variance and predictive value. Drug Alcohol Depend. 1992, 30:187-192.
74. Niaura R., Shadel W.G., Abrams D.B., Monti P.M., Rohsenow D.J., Sirota A. Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. Addict. Behav. 1998, 23:209-224.
75. O'Brien C.P. A range of research-based pharmacotherapies for addiction. Science 1997, 278:66-70.
76. O'Hara P., Portser S.A., Anderson B.P. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addict. Behav. 1989, 14:595-600.
77. Park W.K., Bari A.A., Jey A.R., Anderson S.M., Spealman R.D., Rowlett J.K., Pierce R.C. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J. Neurosci. 2002, 22:2916-2925.
78. Peris J., Decambre C.H., Coleman-Hardee M.L., Simpkins J.W. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H] dopamine release. Brain Res. 1991, 566:255-264.
79. Perkins K.A., Gerlach D., Vender J., Grobe J., Meeker J., Hutchison S. Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine Tob. Res. 2001, 3:141-150.
80. Perkins K.A., Levine M., Marcus M., Shiffman S., D'Amico D., Miller A., Keins A., Ashcom J., Broge M. Tobacco withdrawal in women and menstrual cycle phase. J. Consult. Clin. Psychol. 2000, 68:176-180.
81. Piazza P.V., Le Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Rev. 1997, 25:359-372.
82. Pomerleau C.S., Garcia A.W., Pomerleau O.F., Cameron O.G. The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology 1992, 17:627-638.
83. Protopopescu X., Pan H., Altemus M., Tuescher O., Polanecsky M., McEwen B., Silbersweig D., Stern E. Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16060-16065.
84. Richter R.M., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 1999, 32:254-261.
85. Robbins S.J., Ehrman R.N., Childress A.R., O'Brien C.P. Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend. 1999, 53:223-230.
86. Roca C.A., Schmidt P.J., Altemus M., Deuster P., Danaceau M.A., Putnam K., Rubinow D.R. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J. Clin. Endocr. Metab. 2003, 88:3057-3063.
87. Rogers J.L., Ghee S., See R.E. The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience 2008, 151:579-588.
88. Roth M., Cosgrove K., Carroll M. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci. Biobehav. Rev. 2004, 28:533-546.
89. Rubonis A.V., Colby S.M., Monti P.M., Rohsenow D.J., Gulliver S.B., Sirota A.D. Alcohol cue reactivity and mood induction in male and female alcoholics. J. Stud. Alcohol 1994, 55:487-494.
90. Russo S.J., Festa E.D., Fabian S.J., Gazi F.M., Kraish M., Quiñones-Jenab S., et al. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 2003, 120:523-533.
91. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res. 1995, 675:89-97.
92. Screpanti I., Morrone S., Meco D., Santoni A., Gulino A., Paolini R., Crisanti A., Mathieson B.J., Frati L. Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 p-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J. Immunol. 1989, 142:3378-3383.
93. See R.E., Kruzich P.J., Grimm J.W. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology 2001, 154:301-310.
94. See R.E. Neural substrates of cocaine-cue associations that trigger relapse. Eur. J. Pharmacol. 2005, 526:140-146.
95. See R.E., Elliott J.C., Feltenstein M.W. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl) 2007, 194:321-331.
96. Shaham Y., Funk D., Erb S., Brown T., Walker C.-D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 1997, 17:2605-2614.
97. Shaham Y., Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology 1996, 125:385-391.
98. Sinha R., Fox H.C., Hong K.A., Sofuoglu M., Morgan P.T., Bergquist K.L. Sex steroid hormones, stress response and drug craving in cocaine dependent women: implications for relapse susceptibility. Exp. Clin. Psychopharmacol. 2007, 15:445-452.
99. Snow D., Anderson C. Exploring the factors influencing relapse and recovery among drug and alcohol addicted women. J. Psychosoc. Nurs. Ment. Health Serv. 2000, 38:8-19.
100. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J. Psychiatry Neurosci. 2000, 25:25-36.
101. Stewart J. Psychological and neural mechanisms of relapse. Phil. Trans. R. Soc. B 2008, 363:3147-3158.
102. Stewart J., Vezina P. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res. 1988, 457:287-294.
103. Suzuki T., Ise Y., Tsuda M., Maeda J., Misawa M. Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur. J. Pharmacol. 1996, 314:281-284.
104. Swan G.E., Denk C.E., Parker S.D., Carmelli D., Furze C.T., Rosenman R.H. Risk factors for late relapse in male and female ex-smokers. Addict. Behav. 1988, 13:253-266.
105. Taylor S.E., Klein L.C., Lewis B.P., Gruenewald T.L., Gurung R.A.R., Updegraff J.A. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol. Rev. 2000, 107:411-429.
106. Thompson T.L., Moss R.L. Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and non-genomic-mediated effects. J. Neurochem. 1994, 62:1750-1756.
107. Van den Oever M.C., Goriounova N.A., Li K.W., Van der Schors R.C., Binnekade R., Schoffelmeer A.N.M., Mansvelder H.D., Smit A.B., Spijker S., De Vries T.J. Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking. Nat. Neurosci. 2008, 11(9):1053-1058.
108. Volkow N.D., Wang G.-J., Ma Y., Fowler J.S., Zhu W., Maynard L., Telang R., Vaska P., Ding Y.-S., Wong C., Swanson J.M. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J. Neurosci. 2003, 23:11461-11468.
109. Yu J., Zhang S., Epstein D.H., Fang Y., Shi J., Qin H., Yao S., Le Foll B., Lu L. Gender and stimulus difference in cue-induced responses in abstinent heroin users. Pharmacol. Biochem. Behav. 2007, 86:485-492.